Home > About us > Overview
Samyang Biopharmaceuticals Corporation
Samyang Biopharmaceuticals Corporation, in collaboration with Samyang's central research center, is engaged in the development and marketing of novel drug delivery systems and medical devices.

Samyang Biopharmaceuticals Corporation is focusing its efforts on healthcare as its core strategic business for the 21st century. Samyang Biopharmaceuticals Corporation is developing proprietary and unique core technologies for the development of world class novel drug delivery systems.

In 1996 the company completed construction of its ultra modern, KGMP-approved pharmaceutical formulation plant in Daeduk and started business activity with several transdermal patches.
Daedeok Plant, Pharmaceuticals & Medical Devices
Daedeok Plant, Pharmaceuticals & Medical Devices is an up-to-date
manufacturing facility equipped to produce novel DDS formulations
and medical devices.
The plant was established in July 1996, and approved KGMP
manufacturer in November 1996. The plant also gained ISO9001
accredition in August 1999.
Samyang Biopharmaceuticals R&D Center
The Samyang Biopharmaceuticals R&D Center aims to become world
class research center for research in drug delivery systems.
Utilizing many experiences and know-how within the Samyang group
in the field of polymer chemistry and fine chemicals and also with a close collaboration with international partners, the center is making rapid
progress in developing several innovative dosage forms to deliver drugs more conveniently, efficiently and accurately.
Copyright 2011 by Samyang Biopharmaceuticals Corporation. All rights reserved.